Antiemetic prophylaxis with droperidol in morphine-based intravenous patient-controlled analgesia: a propensity score matched cohort study.
Opioids
Postoperative nausea and vomiting
Prevention
Prophylaxis
Retching
Journal
BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535
Informations de publication
Date de publication:
28 10 2023
28 10 2023
Historique:
received:
12
07
2023
accepted:
23
10
2023
medline:
30
10
2023
pubmed:
29
10
2023
entrez:
29
10
2023
Statut:
epublish
Résumé
There are limited real-world data regarding the use of droperidol for antiemetic prophylaxis in intravenous patient-controlled analgesia (IV-PCA). This study aimed to evaluate the antiemetic benefits and sedation effects of droperidol in morphine-based IV-PCA. Patients who underwent major surgery and used morphine-based IV-PCA at a medical center from January 2020 to November 2022 were retrospectively analyzed. The primary outcome was the rate of any postoperative nausea and/or vomiting (PONV) within 72 h after surgery. Propensity score matching was used to match patients with and without the addition of droperidol to IV-PCA infusate in a 1:1 ratio. Multivariable conditional logistic regression models were used to calculate adjusted odds ratios (aORs) with 95% confidence intervals (CIs). After matching, 1,104 subjects were included for analysis. The addition of droperidol to IV-PCA reduced the risk of PONV (aOR: 0.49, 95% CI: 0.35-0.67, p < 0.0001). The antiemetic effect of droperidol was significant within 36 h after surgery and attenuated thereafter. Droperidol was significantly associated with a lower risk of antiemetic uses (aOR: 0.58, 95% CI: 0.41-0.80, p = 0.0011). The rate of unintentional sedation was comparable between the patients with (9.1%) and without (7.8%; p = 0.4481) the addition of droperidol. Postoperative opioid consumption and numeric rating scale acute pain scores were similar between groups. The addition of droperidol to IV-PCA reduced the risk of PONV without increasing opiate consumption or influencing the level of sedation. However, additional prophylactic therapies are needed to prevent late-onset PONV.
Sections du résumé
BACKGROUND
There are limited real-world data regarding the use of droperidol for antiemetic prophylaxis in intravenous patient-controlled analgesia (IV-PCA). This study aimed to evaluate the antiemetic benefits and sedation effects of droperidol in morphine-based IV-PCA.
METHODS
Patients who underwent major surgery and used morphine-based IV-PCA at a medical center from January 2020 to November 2022 were retrospectively analyzed. The primary outcome was the rate of any postoperative nausea and/or vomiting (PONV) within 72 h after surgery. Propensity score matching was used to match patients with and without the addition of droperidol to IV-PCA infusate in a 1:1 ratio. Multivariable conditional logistic regression models were used to calculate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
RESULTS
After matching, 1,104 subjects were included for analysis. The addition of droperidol to IV-PCA reduced the risk of PONV (aOR: 0.49, 95% CI: 0.35-0.67, p < 0.0001). The antiemetic effect of droperidol was significant within 36 h after surgery and attenuated thereafter. Droperidol was significantly associated with a lower risk of antiemetic uses (aOR: 0.58, 95% CI: 0.41-0.80, p = 0.0011). The rate of unintentional sedation was comparable between the patients with (9.1%) and without (7.8%; p = 0.4481) the addition of droperidol. Postoperative opioid consumption and numeric rating scale acute pain scores were similar between groups.
CONCLUSIONS
The addition of droperidol to IV-PCA reduced the risk of PONV without increasing opiate consumption or influencing the level of sedation. However, additional prophylactic therapies are needed to prevent late-onset PONV.
Identifiants
pubmed: 37898746
doi: 10.1186/s12871-023-02319-2
pii: 10.1186/s12871-023-02319-2
pmc: PMC10612161
doi:
Substances chimiques
Antiemetics
0
Droperidol
O9U0F09D5X
Morphine
76I7G6D29C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
351Informations de copyright
© 2023. The Author(s).
Références
Eur J Anaesthesiol. 1998 May;15(3):304-9
pubmed: 9649989
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Anesth Analg. 1999 Sep;89(3):652-8
pubmed: 10475299
Br J Anaesth. 2002 Feb;88(2):241-5
pubmed: 11878656
Stat Med. 2006 Jun 30;25(12):2084-106
pubmed: 16220490
BMJ Open. 2019 Nov 7;9(11):e031936
pubmed: 31699739
Anesthesiology. 1999 Sep;91(3):693-700
pubmed: 10485781
Br J Anaesth. 1998 Sep;81(3):384-6
pubmed: 9861125
Medicine (Baltimore). 2019 May;98(18):e15442
pubmed: 31045812
Int J Surg. 2015 Mar;15:100-6
pubmed: 25638733
Anesth Analg. 1994 May;78(5):988-94
pubmed: 8161001
BMC Surg. 2021 Apr 1;21(1):177
pubmed: 33794852
Yonsei Med J. 2013 Sep;54(5):1273-81
pubmed: 23918581
Br J Anaesth. 2012 Nov;109(5):742-53
pubmed: 23035051
Anaesthesia. 1993 Oct;48(10):881-4
pubmed: 8031342
Br J Anaesth. 1994 Apr;72(4):460-1
pubmed: 8155452
J Clin Anesth. 1995 Mar;7(2):141-7
pubmed: 7598923
Br J Anaesth. 2018 Feb;120(2):376-383
pubmed: 29406186
Cochrane Database Syst Rev. 2020 Oct 19;10:CD012859
pubmed: 33075160
JA Clin Rep. 2020 Nov 9;6(1):90
pubmed: 33165714
Best Pract Res Clin Anaesthesiol. 2020 Dec;34(4):721-734
pubmed: 33288122
J Chin Med Assoc. 2012 May;75(5):227-33
pubmed: 22632989
J Emerg Med. 2015 Jul;49(1):91-7
pubmed: 25837231
JAMA Surg. 2021 Jun 1;156(6):577-578
pubmed: 33825815
Stat Methods Med Res. 2017 Apr;26(2):796-808
pubmed: 25411322
J Clin Anesth. 2015 Feb;27(1):51-6
pubmed: 25544263
Best Pract Res Clin Anaesthesiol. 2020 Dec;34(4):681-686
pubmed: 33288118
Clin Gastroenterol Hepatol. 2017 Sep;15(9):1338-1349
pubmed: 28529168
Br J Anaesth. 1993 Aug;71(2):296-7
pubmed: 8123411
Anesth Analg. 2020 Aug;131(2):411-448
pubmed: 32467512
Asian J Surg. 2018 Jul;41(4):301-306
pubmed: 28372932
Yonsei Med J. 2014 Sep;55(5):1430-5
pubmed: 25048507
Am J Emerg Med. 2022 Feb;52:212-219
pubmed: 34959024
Nephron. 1976;16(1):31-41
pubmed: 1244564
J Pharm Pharm Sci. 2020;23:220-230
pubmed: 32569560
Anaesthesia. 2001 Jan;56(1):60-5
pubmed: 11167438
Anesth Analg. 1999 Sep;89(3):796-7
pubmed: 10475327
Anesthesiology. 2002 Jul;97(1):287
pubmed: 12131145
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001
Can J Anaesth. 2000 Jun;47(6):537-51
pubmed: 10875717
Br J Anaesth. 2010 Feb;104(2):158-66
pubmed: 20037151
Br J Anaesth. 2002 Dec;89(6):810-3
pubmed: 12453921
Anaesthesia. 2000 Jun;55(6):540-4
pubmed: 10866716